Forecasts data is unavailable for this security.
Consensus recommendation
- 16-Nov-23
- 15-Aug-24
- 19-Sep-24
- 17-Oct-24
- 07-Nov-24
Select bar for recommendation details.
Recommendations | 07-Nov-24 | |
---|---|---|
Buy | 0 | |
Outperform | 0 | |
Hold | 7 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 4 analysts offering 12 month price targets for Aclaris Therapeutics Inc have a median target of 2.50, with a high estimate of 3.00 and a low estimate of 2.00. The median estimate represents a -2.34% decrease from the last price of 2.56.
High | 17.2% | 3.00 |
Med | -2.3% | 2.50 |
Low | -21.9% | 2.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Feb 25, 2025.
Average growth rate | -235.18% |
Average growth rate | +14.98% |
More ▼
Revenue history & estimates in USD
Average growth rate | +18.85% |
Average growth rate | +100.68% |
More ▼